What is CTLP's health score?

CANTALOUPE, INC. (CTLP) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CTLP's estimated fair value?

Based on our 5-year discounted cash flow model, CANTALOUPE, INC.'s estimated fair value is $1.77 per share, representing a -84.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is CTLP undervalued or overvalued?

Our model currently rates CTLP as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CTLP... Refresh in a moment for the full analysis.

CANTALOUPE, INC. (CTLP)

Technology Overvalued low weak

$11.2

Updated: 2026-06-06

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

60 Healthy

Relative Value

5 Stressed

Capital Allocation

50 Mixed

Risk

80 Strong

Est. Fair Value $1.77

DCF Upside -84.2%

Sector Rank #2749 of 7597

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.